Cargando…
Cheminformatics-Based Drug Design Approach for Identification of Inhibitors Targeting the Characteristic Residues of MMP-13 Hemopexin Domain
BACKGROUND: MMP-13, a zinc dependent protease which catalyses the cleavage of type II collagen, is expressed in osteoarthritis (OA) and rheumatoid arthritis (RA) patients, but not in normal adult tissues. Therefore, the protease has been intensively studied as a target for the inhibition of progress...
Autores principales: | Kothapalli, Roopa, Khan, Asif M., Basappa, Gopalsamy, Anupriya, Chong, Yap Seng, Annamalai, Loganath |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930869/ https://www.ncbi.nlm.nih.gov/pubmed/20824169 http://dx.doi.org/10.1371/journal.pone.0012494 |
Ejemplares similares
-
Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategy
por: Yosef, Gal, et al.
Publicado: (2021) -
Hemopexin and Cancer
por: Fiorito, Veronica, et al.
Publicado: (2022) -
Cheminformatics Microservice: unifying access to open cheminformatics toolkits
por: Chandrasekhar, Venkata, et al.
Publicado: (2023) -
Targeting the Hemopexin-like Domain of Latent Matrix
Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor
Prevents the Formation of Focal Adhesion Junctions
por: Alford, Vincent M., et al.
Publicado: (2017) -
Implementing cheminformatics
por: Guha, Rajarshi
Publicado: (2019)